← The Wire
ANVSNYSE
Annovis Bio, Inc.
Pharmaceutical Preparations · DE · CIK 1477845
Annovis Bio develops buntanetap, a drug candidate to treat neurodegenerative diseases by inhibiting neurotoxic protein synthesis
$76M
Market cap
$1.86
Last close
+8.1%
1D
+5.1%
5D
893K
Volume
Price · last 39 sessions-18.4%
May 4L $1.65 · H $2.40Jun 29
149
Total filings
Jun 17, 2026
Last filing
12/31
Fiscal year end
8-KShareholder VoteJun 17, 20268-KMaterial Agreement · Reg FD DisclosureMay 20, 2026424B5424B5May 20, 2026424B5424B5May 19, 202610-Q10-QMay 15, 20268-KResults of OperationsMay 15, 2026DEFA14ADEFA14AApr 30, 2026DEF 14AFORM DEF 14AApr 30, 20268-KMaterial Agreement · Reg FD DisclosureApr 10, 2026424B5424B5Apr 9, 20268-KExecutive ChangeMar 25, 20268-KResults of OperationsMar 16, 202610-K10-KMar 13, 20268-KReg FD DisclosureFeb 12, 20268-KReg FD DisclosureJan 28, 20268-KResults of OperationsNov 13, 202510-Q10-QNov 12, 20258-KMaterial Agreement · Company UpdateOct 28, 2025424B5424B5Oct 28, 20258-KMaterial Agreement · Reg FD DisclosureOct 14, 2025424B5424B5Oct 14, 20258-KExecutive ChangeSep 29, 20258-KExecutive ChangeAug 15, 202510-Q10-QAug 12, 20258-KResults of OperationsAug 12, 20258-KShareholder VoteJun 23, 20258-KReg FD DisclosureJun 20, 20258-KExecutive Change · Results of OperationsMay 13, 202510-Q10-QMay 13, 2025DEFA14ADEFA14AMay 1, 2025DEF 14ADEF 14AApr 30, 20258-KDelisting Notice · Executive ChangeMar 27, 202510-K10-KMar 21, 20258-KResults of OperationsMar 21, 20258-KReg FD DisclosureFeb 5, 20258-KMaterial Agreement · Company UpdateFeb 5, 2025424B5424B5Feb 4, 2025424B5424B5Feb 3, 20258-KReg FD DisclosureDec 11, 20248-KMaterial AgreementDec 11, 2024424B5424B5Dec 11, 20248-KExecutive ChangeDec 9, 20248-KResults of OperationsNov 12, 202410-Q10-QNov 8, 20248-KCompany UpdateOct 15, 20248-KReg FD DisclosureSep 30, 20248-KResults of OperationsAug 15, 202410-Q10-QAug 14, 20248-KReg FD DisclosureAug 6, 20248-KReg FD DisclosureJul 16, 20248-KReg FD DisclosureJul 10, 20248-KReg FD DisclosureJul 2, 20248-KShareholder VoteJun 13, 20248-KReg FD DisclosureJun 11, 20248-KReg FD DisclosureJun 5, 20248-KReg FD DisclosureMay 21, 20248-KResults of OperationsMay 13, 202410-Q10-QMay 10, 20248-KReg FD DisclosureMay 9, 2024DEFA14ADEFA14AMay 6, 20248-KReg FD DisclosureMay 6, 20248-KCompany UpdateMay 2, 20248-KExecutive ChangeMay 1, 2024424B5424B5May 1, 2024DEFA14ADEFA14AApr 29, 2024DEF 14ADEF 14AApr 29, 20248-KMaterial AgreementApr 26, 20248-KResults of OperationsApr 3, 202410-K10-KMar 29, 20248-KCompany UpdateMar 22, 2024424B5424B5Mar 22, 20248-KMaterial AgreementMar 21, 20248-KReg FD DisclosureMar 20, 20248-KCompany UpdateMar 20, 2024424B5424B5Mar 19, 2024424B5424B5Mar 19, 20248-KMaterial AgreementMar 15, 202410-Q10-QNov 8, 2023SC 13GSC 13GNov 8, 20238-KMaterial Agreement · Results of OperationsNov 1, 2023
Insider Activity
◆ Cluster Buy · 2 insidersIn the 90 days to Dec 8, 2025: 2 insiders bought $2.8M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 8, 2025 | Hoffman Michael BDirector | Buy | 30,000 | $4.34 | $130K |
| Dec 8, 2025 | Hoffman Michael BDirector | Buy | 15,000 | $4.24 | $64K |
| Nov 24, 2025 | Hoffman Michael BDirector | Buy | 28,096 | $4.15 | $117K |
| Nov 24, 2025 | Hoffman Michael BDirector | Buy | 28,096 | $4.15 | $117K |
| Nov 24, 2025 | Hoffman Michael BDirector | Buy | 9,200 | $3.85 | $35K |
| Nov 24, 2025 | Hoffman Michael BDirector | Buy | 9,200 | $3.85 | $35K |
| Nov 24, 2025 | Hoffman Michael BDirector | Buy | 1,489 | $4.13 | $6K |
| Nov 24, 2025 | Hoffman Michael BDirector | Buy | 1,489 | $4.13 | $6K |
| Nov 24, 2025 | Hoffman Michael BDirector | Buy | 415 | $4.14 | $2K |
| Nov 24, 2025 | Hoffman Michael BDirector | Buy | 415 | $4.14 | $2K |
| Nov 21, 2025 | Hoffman Michael BDirector | Buy | 10,000 | $3.50 | $35K |
| Nov 21, 2025 | Hoffman Michael BDirector | Buy | 10,000 | $3.49 | $35K |
| Nov 14, 2025 | Hoffman Michael BDirector | Buy | 15,000 | $2.11 | $32K |
| Oct 28, 2025 | Hoffman Michael BDirector | Buy | 975,610 | $2.05 | $2.0M |
| Oct 28, 2025 | Maccecchini Maria-LuisaPresident & CEO | Buy | 97,561 | $2.05 | $200K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance